Health and Human Services, the National Institute of Mi-
nority Health and Health Disparities, and the Indian 
Health Service, shall award competitive grants to eligible 
entities to support such entities in developing and imple-
menting accessible, multilingual, and culturally competent 
public awareness campaigns about COVID–19 directed at 
racial and ethnic minority, rural, and other vulnerable 
populations that have experienced health disparities dur-
ing the COVID–19 public health emergency related to 
testing, infections, hospitalizations, ICU admissions, and 
deaths. 
(b) ELIGIBLE ENTITIES.—To be eligible to receive a 
grant under this section, an entity shall be a State, local, 
Tribal, or territorial health department, a nonprofit com-
munity-based organization, a Tribal organization, an 
urban Indian organization, or a health care provider, or 
a nonprofit faith-based organization. 
(c) PRIORITIZATION.—When awarding grants under 
this section, the Secretary shall prioritize entities serving 
communities where the greatest health disparities exist 
with respect to testing access, infections, hospitalizations, 
and deaths related to COVID–19, impacting racial and 
ethnic minority, rural, and other vulnerable populations. 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
(d) REQUIREMENTS.—An entity awarded a grant 
under this section shall conduct a public awareness cam-
paign that— 
(1)(A) provides to the public information, based 
on scientific evidence, about the benefits of being 
tested for COVID–19, the availability of COVID–19 
testing with no cost-sharing for most United States 
residents, and the actions that individuals can take 
to protect themselves from COVID–19, including 
masking and social distancing; and 
(B) dispels misinformation about COVID–19 
symptoms, testing, or treatment; 
(2) uses print, radio, or internet media, or 
other forms of public communication; and 
(3) communicates in the language or languages 
necessary to reach racial and ethnic minority, rural, 
and other vulnerable populations in the applicable 
region that have experienced health disparities dur-
ing the COVID–19 public health emergency related 
to testing, infections, hospitalizations, ICU admis-
sions, and deaths. 
(e) COORDINATION.—The public health campaigns 
supported by grants awarded under this section shall be 
complementary to, and coordinated with, any other Fed-
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
eral, State, or local efforts, including the action plan de-
scribed in section 3, as appropriate. 
(f) TIMING.—The Secretary shall award the grants 
under this section not later than 60 days after the date 
of enactment of this Act. 
(g) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$10,000,000 for fiscal year 2020. 
SEC. 6. VACCINE SAFETY PUBLIC AWARENESS CAMPAIGN. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion and in coordination with the Office of Minority 
Health, and, as appropriate, the relevant Offices of Minor-
ity Health in the Department of Health and Human Serv-
ices, the National Institute of Minority Health and Health 
Disparities, and the Indian Health Service, shall establish 
grant funding opportunities for eligible entities to dissemi-
nate COVID–19 vaccination information. 
(b) ELIGIBLE ENTITIES.—To be eligible to receive a 
grant under this section, an entity shall be a State, local, 
Tribal, or territorial health department, an urban Indian 
organization, a nonprofit community-based organization, 
or a nonprofit faith-based organization. 
(c) USE OF FUNDS.— 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
(1) IN GENERAL.—Entities receiving a grant 
under this section shall use such grant funds to— 
(A) increase awareness to the benefit of re-
ceiving a COVID–19 vaccine, and include infor-
mation on where the vaccine can be obtained; 
and 
(B) create and disseminate culturally and 
linguistically appropriate messaging. 
(2) ADDITIONAL
GRANT
FUNDS.—The Sec-
retary shall have discretion to award additional 
grant funding under this section to broaden the 
grant recipient’s vaccine public safety awareness 
campaign to include routine immunizations and gen-
eral influenza vaccine messaging. 
(d) PRIORITIZATION.—In awarding grants under this 
section, the Secretary shall give priority to eligible entities 
in either urban or rural communities (or a combination 
of urban and rural communities) that serve vulnerable 
populations, including ethnic minority populations, which 
may include low-income, uninsured, and medically under-
served individuals or populations with historically low 
rates of receiving vaccines. 
(e) TIMING.—The Secretary shall awards the grants 
under this section not later than 60 days after the date 
on the earlier of the date on which the Food and Drug 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
Administration licenses a COVID–19 vaccine under sec-
tion 351 of the Public Health Service Act (42 U.S.C. 262) 
or the date on which a manufacturer begins to distribute 
a COVID–19 vaccine to public or private entities pursuant 
to an emergency use authorization under section 564 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360bbb–3). 
(f) AUTHORIZATION OF APPROPRIATIONS.—There is 
authorized to be appropriated to carry out this section 
$5,000,000 for fiscal year 2020. 
SEC. 7. ADDENDUM TO TESTING PLANS TO ADDRESS DIS-
PARITIES. 
(a) IN GENERAL.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, shall report to the Committee on Appropriations and 
the Committee on Health, Education, Labor, and Pen-
sions of the Senate, and the Committee on Appropriations 
and the Committee on Energy and Commerce of the 
House of Representatives, on State testing plans referred 
to under the heading ‘‘Public Health and Social Services 
Emergency Fund’’ under the heading ‘‘Office of the Sec-
retary’’ under the heading ‘‘Department of Health and 
Human Services’’ of title I of division B of the Paycheck 
Protection Program and Health Care Enhancement Act 
(Public Law 116–139). 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
(b) REQUIREMENT TO DEVELOP ADDENDUM.— 
(1) IN GENERAL.—The Secretary shall solicit 
States, territories, and Indian tribes to develop an 
addendum to testing plans described in subsection 
(a), to specifically address testing plans for racial 
and ethnic minority, rural, and other vulnerable pop-
ulations experiencing health disparities related to 
COVID–19 testing, infections, hospitalizations, ICU 
admissions, or deaths. The Secretary shall model 
questions for the addendum based on the original 
testing plans. 
(2) FUNDING.—To carry out this subsection, 
the Secretary shall use amounts appropriated under 
the heading ‘‘Public Health and Social Services 
Emergency Fund’’ under the heading ‘‘Office of the 
Secretary’’ under the heading ‘‘Department of 
Health and Human Services’’ of title I of division B 
of the Paycheck Protection Program and Health 
Care Enhancement Act (Public Law 116–139). 
SEC. 8. DEFINITIONS. 
In this Act— 
(1) the term ‘‘COVID–19 public health emer-
gency’’ means the public health emergency first de-
clared by the Secretary of Health and Human Serv-
ices under section 319 of the Public Health Service 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
Act (42 U.S.C. 247d) on January 31, 2020, with re-
spect to COVID–19; 
(2) the term ‘‘ICU’’ means intensive care unit; 
(3) the terms ‘‘racial and ethnic minority 
group’’ and ‘‘racial and ethnic minority’’ have the 
meaning given the term ‘‘racial and ethnic minority 
group’’ in section 1707(g) of the Public Health Serv-
ice Act (42 U.S.C. 300u–6(g)); 
(4) the term ‘‘relevant Offices of Minority 
Health in the Department of Health and Human 
Services’’ may include— 
(A) the Office of Extramural Research, 
Education, and Priority Populations of the 
Agency for Healthcare Research and Quality; 
(B) the Office of Minority Health and 
Health Equity of the Centers for Disease Con-
trol and Prevention; 
(C) the Office of Minority Health of the 
Centers for Medicare & Medicaid Services; 
(D) the Office of Minority Health and 
Health Equity of the Food and Drug Adminis-
tration; 
(E) the Office of Health Equity of the 
Health Resources and Services Administration; 
and 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS
(F) the Office of Behavioral Health Equity 
of the Substance Abuse and Mental Health 
Services Administration; and 
(5) the term ‘‘Secretary’’, unless indicated oth-
erwise, means the Secretary of Health and Human 
Services 
(6) the terms ‘‘Indian Tribe’’ and ‘‘Tribal orga-
nization’’ have the meanings given the terms ‘‘In-
dian tribe’’ and ‘‘tribal organization’’ in section 4 of 
the Indian Self-Determination and Education Assist-
ance Act (25 U.S.C. 5304); and 
(7) the term ‘‘urban Indian organization’’ has 
the meaning given the term in section 4 of the In-
dian Health Care Improvement Act (25 U.S.C. 
1603). 
Æ 
VerDate Sep 11 2014 
03:47 Sep 15, 2020
Jkt 099200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6301
E:\BILLS\H8203.IH
H8203
SSpencer on DSK126QN23PROD with BILLS